• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 13th April 2010

OHE Awarded DH Grant for EQ-5D Research

The OHE has won a £325,000 grant from the UK Department of Health that focuses on developing a new health status index – the 5 level EQ-5D –that will capture smaller changes in health related quality of life. The OHE…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
smformbeingticked3-27-10

The OHE has won a £325,000 grant from the UK Department of Health that focuses on developing a new health status index – the 5 level EQ-5D –that will capture smaller changes in health related quality of life.

The OHE has been awarded a £325,000 Policy Research Programme grant by the Department of Health.  The fifteen-month project focuses on a new health status index – the 5 level (5L) EQ-5D — that will capture smaller changes in health related quality of life than does the current 3 level (3L) instrument.  The EQ-5D is arguably the most important patient-reported outcomes measure (PROM) currently in use.  In England, for example, it underpins technology appraisals submitted to NICE and is used by the PROMs programme to assess the quality of care provided in different settings.

The research for this grant consists of three sets of studies. The first will map the 5L to 3L values to produce an interim set of measures applicable while international research resolves important methodological issues with the 5L approach.  The EuroQol Group has similar research underway in Scotland, Poland and The Netherlands.  In England, 1,000 patients will be involved who have one of four diagnoses: rheumatoid arthritis, depression, multiple sclerosis or a recent history of myocardial infarction.

The second study will focus on improving Time Trade Off (TTO) methodology, focusing on Lead Time TTO (LT-TTO).  The objective is to develop a better understanding of the characteristics of the data generated by LT-TTO, improve data collection tools, and provide information for selecting the particular variant of LT-TTO to be used in subsequent research.  TTO helps translate EQ-5D indexes into values that can underpin health care allocation and access decisions. The third study builds on the second, with the aim of investigating alternatives for addressing  technical issues presented by the increase from 243 states under 3L to 3,125 under 5L.  Specifically, a hybrid approach using LT-TTO and discrete choice (DC) methods will be tested.  This study is part of a wider four-country study, involving the Netherlands, Italy and Canada.

The research programme will yield both an interim value set for the EQ-5D-5L, and methodological improvements in approaches to valuation that can be used to produce new national value sets for use in economic evaluation.

Investigators on the grant include: Prof Nancy Devlin, OHE; Dr Andrew Lloyd, Oxford Outcomes Ltd; Dr Aki Tsuchiya, University of Sheffield; Mr Koonal Shah, OHE.  Please contact Nancy Devlin for additional information.

Official project title: An interim EQ-5D-5L value set for England and development of EQ-5D-5L valuation methods.

Editor’s Note: OHE subsequently was awarded a second grant that puts into practice the results of this one. Click here for more information.      

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Grants

Related News

  • News
  • December 2019

New OHE Research Funding: Improving Labour Productivity in Primary Care

Read more
  • News
  • October 2019

Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase

Read more
  • News
  • May 2019

OHE is Leading Research to Develop EQ-5D ‘Bolt-ons’ for Cognition and Vision

Read more
  • News
  • September 2018

UKRI Funds OHE Collaboration in Student Mental Health Research Network

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!